These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2206774)

  • 1. Orally administered streptococcal preparation, OK-432 augments the antitumor immunity of patients with gastric or colorectal cancer.
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tobe T
    Biotherapy; 1990; 2(3):213-22. PubMed ID: 2206774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers.
    Satoh K; Kan N; Okino T; Mise K; Yamasaki S; Harada T; Hori T; Ohgaki K; Tobe T
    Biotherapy; 1993; 6(1):41-9. PubMed ID: 8507544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes.
    Mizutani Y; Nio Y; Yoshida O
    Cancer; 1992 Jun; 69(12):2999-3007. PubMed ID: 1591693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative immunotherapy in patients with gastric cancer--with special reference to analysis with monoclonal antibodies of T-lymphocyte subsets and interleukin-2 oral administration of OK-432 (Picibanil)].
    Izumi M
    Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):27-32. PubMed ID: 8437550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.
    Hanaue H; Kim DY; Kubota M; Kurosawa T; Shikata J; Kondoh Y; Ogoshi K; Makuuchi H; Nakasaki H; Mitomi T
    Tokai J Exp Clin Med; 1987 May; 12(2):97-102. PubMed ID: 3502432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer].
    Nio Y; Tobe T
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1436-8. PubMed ID: 2586435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes.
    Yamaguchi Y; Miyahara E; Ohshita A; Kawabuchi Y; Ohta K; Shimizu K; Minami K; Hihara J; Sawamura A; Toge T
    Br J Cancer; 2003 Nov; 89(10):1876-84. PubMed ID: 14612896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of cytotoxicity of tumor-infiltrating lymphocytes by biological response modifiers.
    Gotoh K; Gouchi A; Akura Y; Tanaka N; Orita K
    Int J Immunopharmacol; 1991; 13(5):485-92. PubMed ID: 1783460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution of lymphocytes to tumor tissue and regional lymph nodes in patients with gastric cancer--the effects of oral administration of OK-432].
    Yoshikawa T; Saito M; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Ono Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1813-6. PubMed ID: 10560401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients.
    Gochi A; Orita K; Fuchimoto S; Tanaka N; Ogawa N
    Br J Cancer; 2001 Feb; 84(4):443-51. PubMed ID: 11207036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive multi-institutional study on postoperative adjuvant immunotherapy with oral streptococcal preparation OK-432 for patients after gastric cancer surgery. Kyoto Research Group for Digestive Organ Surgery.
    Ann Surg; 1992 Jul; 216(1):44-54. PubMed ID: 1632701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.
    Hori T; Mise K; Kan N; Okino T; Satoh K; Yamasaki S; Teramura Y; Harada T; Ohgaki K; Kodama H
    Biotherapy; 1992; 5(1):21-9. PubMed ID: 1389900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in immunological parameters in lung cancer patients undergoing immunotherapy with streptococcal preparation OK-432.
    Watanabe Y; Shimizu J; Hashizume Y; Tsunamura Y; Yamada T; Iwa T; Sakai S; Murayama T; Koshimura S; Saito M
    Biotherapy; 1990; 2(3):235-45. PubMed ID: 2206775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.
    Takeshita M; Makita F; Takeyoshi I; Ishikawa H; Nakamura S; Owada S; Miyamoto Y; Izuo M; Kurashige S
    Jpn J Surg; 1990 May; 20(3):316-26. PubMed ID: 2359208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augumentation of splenic antitumor immunity by local immunotherapy in gastric cancer patients.
    Wakasugi T; Takeda T; Monden T; Katsumoto Y; Sakita I; Nagaoka H; Fukunaga M; Tomita N; Kobayashi T; Shiozaki H; Shimano T; Monden M
    Biotherapy; 1997; 10(2):99-106. PubMed ID: 9373731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of OK-432 intraportal administration on cell-mediated immune responses].
    Minamimura T; Katsuyama S; Yamasaki K; Ookami H; Okamoto M; Masuyama K; Yamamoto K; Takemori S; Arai H; Sakamoto T; Tazawa K; Fujimaki M
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1867-9. PubMed ID: 9382553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.